The World of Health & Medicine News

Global leaders commit $1.9 billion to eradicate polio amid funding cuts

Global leaders commit $1.9 billion to eradicate polio amid funding cuts

Global leaders pledged $1.9 billion to advance polio eradication on Monday, accelerating efforts to protect ​370 million children from polio each year amid ‌significant funding cuts.

The budget of the Global Polio Eradication Initiative, a partnership ‌that includes the World Health Organization and the Gates Foundation, is expected to take a 30% cut in 2026 and has a funding gap of $1.7 billion up to 2029.

The shortfall ⁠is largely due to ‌a global pullback from foreign aid, led by the U.S., which is withdrawing from the ‍WHO, although its future funding for polio is not yet final. Other wealthy donor governments like Germany and the UK have also ​made cuts.

The GPEI partners, in response, plan to focus ‌more on surveillance and vaccination in areas with a high risk of polio transmission.

“The new support pledged in Abu Dhabi will be instrumental in helping the GPEI reach all children in the final endemic countries and stop variant ⁠polio outbreaks around the world.” said ​Tedros Ghebreyesus, Director-General of the World ​Health Organization.

The pledging event, hosted by Mohamed bin Zayed Foundation for Humanity at Abu Dhabi Finance ‍Week, will reduce ⁠the remaining resource gap for GPEI’s 2022 to 2029 strategy to $440 million.

Pledges were made from a diverse ⁠group of donors and countries, including $1.2 billion from the Gates Foundation and $450 ‌million from Rotary International.

spot_img

Explore more

spot_img

Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in...

Health Rounds: Regeneron drug wipes out residual multiple myeloma cells in small trial A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of...

FDA approves first gene therapy for rare immune disorder

FDA approves first gene therapy for rare immune disorder The U.S. Food and Drug Administration said on Tuesday it had approved the first gene therapy...

STOPPING GLP-1 DRUGS DURING PREGNANCY CARRIES RISKS

STOPPING GLP-1 DRUGS DURING PREGNANCY CARRIES RISKS Stopping GLP-1 weight-loss drugs before pregnancy appears to increase the risk of complications and preterm delivery, a new...

US FDA approves first drug under new fast-track review program

US FDA approves first drug under new fast-track review program The U.S. Food and Drug Administration approved on Tuesday the ​first drug under its new...

US FDA qualifies first AI tool to help speed liver disease...

US FDA qualifies first AI tool to help speed liver disease drug development The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed...

Vertex’s gene therapy shows promise in younger children with blood disorders

Vertex's gene therapy shows promise in younger children with blood disorders Vertex Pharmaceuticals (VRTX.O), opens new tab said on Saturday its gene therapy helped children aged between...

Regeneron’s experimental therapy combo effective in untreated cancer patients

Regeneron's experimental therapy combo effective in untreated cancer patients  Regeneron said on Saturday its experimental cancer combination therapy was effective and showed disappearance of the...

Your daily orange juice could be helping your heart

Your daily orange juice could be helping your heart Most of us think of orange juice as a simple breakfast habit, something you pour without...